Intel Capital led a series B round that took Tibit's total funding to almost $34m and which will fund the commercial deployment of its pluggable ethernet device.

Existing backer Kakao Ventures reinvested in the AI-based drug discovery technology developer as part of an $11.5m round led by Mirae Asset Capital.

Online tutoring service Vedantu received $5m from TAL Education as part of an $11m series B round in November, the corporate has disclosed.

Goldman Sachs led the pension platform developer's latest round, which included Allianz Life Ventures, Nationwide and BNY Mellon.

SMBC, Shinsei Bank, Mitsubishi UFJ and Kyoto Chuo Shinkin all backed cancer therapy developer Chordia Therapeutics’ latest round, which follows a Takeda-backed series A.

Oncology therapeutics developer Fusion Pharmaceticals closed a $105 round, featuring several corporate investors. The deal forms part of the growing broad oncology space, which has seen much attention from corporate venturers in recent years.

The radiography image analysis platform developer has completed a series B round that was led by new distribution partner Marubeni.

Existing investors Aurora and Fosun RZ Capital both contributed to a $14.9m round that was co-led by Mandra Capital and Haitong Creative Capital.

Unilever Ventures returned to participate in an L Catterton-led series B round that will fund the hair supplement developer's marketing and research and development activities.

New Oriental Education & Technology Group co-led the online education management platform's series B round with China Growth Capital.